Results
1 -
10 of
47
(Click
here to explore results)
- From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes. Kyung Bo Kim, Craig M. Crews
, Nat. Prod. Rep.
, 2013
, 30
, 600
- Revisiting the role of the immunoproteasome in the activation of the canonical NF-κB pathway. Eun Ryoung Jang, Na-Ra Lee, Songhee Han, Ying Wu, Lalit Kumar Sharma, Kimberly Cornish Carmony, James Marks, Do-Min Lee, Jung-Ok Ban, Marie Wehenkel, Jin Tae Hong, Kyung Bo Kim, Wooin Lee
, Mol. BioSyst.
, 2012
, 8
, 2295
- Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors. Grace E. Hubbell, Jetze J. Tepe
, RSC Chem. Biol.
, 2020
, 1
, 305
- An antibody-based amperometric biosensor for 20S proteasome activity and inhibitor screening. Madalina M. Barsan, Victor C. Diculescu
, Analyst
, 2021
, 146
, 3216
- Targeting eukaryotic proteases for natural products-based drug development. Fatma H. Al-Awadhi, Hendrik Luesch
, Nat. Prod. Rep.
, 2020
, 37
, 827
- Natural product and natural product derived drugs in clinical trials. Mark S. Butler, Avril A. B. Robertson, Matthew A. Cooper
, Nat. Prod. Rep.
, 2014
, 31
, 1612
- Mixing of peptides and electrophilic traps gives rise to potent, broad-spectrum proteasome inhibitors. Martijn Verdoes, Bogdan I. Florea, Wouter A. van der Linden, Didier Renou, Adrianus M. C. H. van den Nieuwendijk, Gijs A. van der Marel, Herman S. Overkleeft
, Org. Biomol. Chem.
, 2007
, 5
, 1416
- Exploring dual electrophiles in peptide-based proteasome inhibitors: carbonyls and epoxides. Bo-Tao Xin, Gerjan de Bruin, Martijn Verdoes, Dmitri V. Filippov, Gijs A. van der Marel, Herman S. Overkleeft
, Org. Biomol. Chem.
, 2014
, 12
, 5710
- Exploiting nature's rich source of proteasome inhibitors as starting points in drug development. Melissa Ann Gräwert, Michael Groll
, Chem. Commun.
, 2012
, 48
, 1364
- Natural products: chemical instruments to apprehend biological symphony. Mathieu Pucheault
, Org. Biomol. Chem.
, 2008
, 6
, 424